Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Weight on Doxorubicin and Cyclophosphamide PK
NCT01537029Phase 4Completed
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Feb 2012
- Primary completion
- Dec 2016
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated liposomal doxorubicin, cyclophosphamide in breast cancer, sponsored by Texas Tech University Health Sciences Center. Started Feb 2012; status: completed.
02
Drugs
pegylated liposomal doxorubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01537029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537029.